References in periodicals archive ?
Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome.
Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease.
Increased risk of depressive disorders in women with polycystic ovary syndrome.
Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome," The Journal of Clinical Endocrinology and Metabolism, vol.
Improved efficacy of low-dose spironolactone and metformin combination than ei ther drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
005) had ultrasound features of polycystic ovary syndrome than Caucasian women (3).
Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
Ultra-short metformin pretreatment for clomiphene citrate- resistant polycystic ovary syndrome.